Candel Therapeutics, Inc. CADL
11.02
(0.53)
(4.59%)
as of 25 Sep
- Market cap
- $883.8M
- P/E
- 0.0×
Follow CADL
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
— | — | — | 408.14 | 1,180.70 | 661.64 | 661.64 | — |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
— | — | — | (7.41) | (28.18) | (18.40) | (18.40) | — |
P/B ratio |
— | — | — | 1.07 | 2.30 | 0.00 | 0.00 | — |
Price to Tangible BV |
— | — | — | 1.07 | 2.30 | 0.00 | 0.00 | — |
EV/Sales |
— | — | — | 18.19 | 527.76 | 473.49 | 473.49 | — |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
— | — | — | (0.07) | (2.97) | (3.91) | (3.91) | — |
EV/FCF |
— | — | — | (0.07) | (2.74) | (3.43) | (3.43) | — |
Quick Ratio |
13.31 | 2.74 | 2.50 | 12.48 | 15.41 | 7.44 | 31.96 | — |
Current Ratio |
13.49 | 2.77 | 2.59 | 12.81 | 15.84 | 7.46 | 32.06 | — |
Net Debt/EBITDA |
1.53 | 2.78 | 0.38 | 1.44 | 3.22 | 2.49 | 4.96 | — |
Debt/Assets |
37.65% | 11.70% | 51.64% | 27.43% | 0.63% | 2.47% | 0.92% | 0.00% |
Debt/Equity |
0.91 | 0.19 | 1.67 | 0.45 | 0.01 | (0.04) | 0.01 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — |
Operating CF/Net income |
1.00 | 0.49 | 0.90 | 1.67 | 0.62 | 0.51 | 0.63 | — |
Capex/Depreciation |
(0.66) | (0.02) | (0.29) | (1.67) | (7.91) | (16.22) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (64.58%) | (139.56%) | (125.50%) | (33.61%) | (178.06%) | 111.90% | 52.15% | — | |
| (32.91%) | (74.53%) | (63.82%) | (22.52%) | (56.67%) | (42.00%) | (35.90%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(33.48%) | (80.59%) | (146.94%) | (26.56%) | (43.30%) | (53.22%) | (18.63%) | — |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 16,629.60% | 12,142.40% | 7,003.20% | 5,251.20% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 11,248.00% | 8,538.40% | 4,144.80% | 2,044.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 1,845.60% | 2,370.40% | 1,685.60% | 0.00% | — |
Graham Net Nets |
— | — | — | 0.82 | 0.41 | (0.60) | (0.60) | — |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
— | — | — | (36.72%) | (31.64%) | (33.03%) | (33.03%) | — |
Free Cash Flow Yield |
— | — | — | (64.13%) | (16.30%) | (20.87%) | (20.87%) | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | — |
Operating CF per Share |
(0.72) | (0.85) | (1.18) | (1.09) | (1.18) | (0.78) | (0.18) | — |
Capex per Share |
(0.01) | 0.00 | (0.01) | (0.04) | (0.10) | (0.13) | 0.00 | — |
Free Cash Flow per Share |
(0.73) | (0.85) | (1.19) | (1.13) | (1.27) | (0.91) | (0.18) | — |
Cash per Share |
2.26 | 3.24 | 1.22 | 2.43 | 4.38 | 3.02 | 1.55 | — |
Shareholders Equity per Share |
0.98 | 2.09 | 0.44 | 1.66 | 3.40 | (2.03) | 1.41 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.98 | 2.09 | 0.44 | 1.66 | 3.40 | (2.03) | 1.41 | — |
Free Cash Flow |
(38.87) | (27.04) | (34.52) | (32.72) | (24.05) | (10.55) | (5.18) | — |
Working Capital |
112.39 | 66.28 | 22.61 | 66.33 | 79.58 | 30.43 | 43.80 | — |
Capital Expenditures |
(0.56) | (0.02) | (0.28) | (1.30) | (1.83) | (1.48) | (0.16) | — |
Net Current Asset Value |
48.12 | 63.27 | 8.34 | 41.97 | 59.88 | (26.70) | 40.33 | — |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 10.38 | 14.68 | 11.81 | 0.00 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | (15,035.20%) | (28,899.20%) | (14,144.00%) | (6,592.00%) | — |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.51 | 0.45 | 0.30 | 0.18 | 0.06 | 0.03 | 0.10 | — |
Cash ROIC |
(18.26%) | (16.10%) | (53.94%) | (25.77%) | (17.68%) | (95.34%) | (6.48%) | — |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Payables |
0.68 | 0.33 | 0.40 | 0.99 | 1.26 | 0.57 | 0.57 | — |
Average Assets |
116.03 | 74.03 | 59.45 | 83.45 | 63.74 | 42.09 | 22.95 | — |
Average Common Equity |
59.12 | 39.54 | 30.23 | 55.93 | 20.29 | (15.80) | (15.80) | — |
Columns are period end dates